Kamran Tavangar

Kamran Tavangar has over 20 years of experience in pharmaceuticals and vaccines. Prior to joining Affinivax, Dr. Tavangar was Vice President of Strategic Product Development at Visterra. Dr. Tavangar previously served in various operational and strategic positions with Novartis for 19 years. Most recently he was the Global Head of Strategic Planning at Novartis Vaccines and Diagnostics, subsequent to being Head of Strategic Global Marketing at Novartis Vaccines. Previously, Dr. Tavangar was the Business Unit Head for Novartis Oncology in Australia. He also served as VP Finance for Novartis Pharmaceuticals USA, as well as Head of Investor Relations for Novartis Corporation USA. Dr. Tavangar received his AB in Molecular Biology from UC Berkeley, PhD in Physiology from Stanford University, and MBA from MIT’s Sloan School of Management.

Kamran Tavangar is the Chief Operating Officer at Affinivax, based in United States, North America. With a background in Biotechnology, Kamran Tavangar has a rich history of leadership and innovation.Kamran Tavangar studied MBA Strategy and Finance at Massachusetts Institute of Technology. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.